KUMAR AMIT

Executive buyer

Director, Chief Executive Officer · Anixa Biosciences Inc

Every open-market stock purchase KUMAR AMIT has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where those buys landed inside insider clusters and how the prices paid compare to where the stock trades now.

Total bought
$168.1K
Open-market buys
11
Companies
1
Last buy
Oct 30, 2026

Where the buys stand today

Cluster participation

Qualifying buys grouped with other insiders buying the same stock — the pattern this site exists to catch.

All reported buys

DateTickerSharesPriceValueFiling
Oct 30, 2026
ANIXcluster
5,000$3.17$15.9KSEC ↗
Oct 22, 2026
ANIXcluster
8,000$2.72$21.8KSEC ↗
Sep 24, 2026
ANIXcluster
7,000$2.78$19.5KSEC ↗
Sep 10, 2026
ANIXcluster
3,000$2.75$8.3KSEC ↗
Sep 10, 2026
ANIXcluster
5,000$2.76$13.8KSEC ↗
Jul 31, 2026
ANIXcluster
5,000$3.47$17.4KSEC ↗
Jul 27, 2026
ANIXcluster
5,000$3.44$17.2KSEC ↗
Jul 27, 2026
ANIXcluster
3,188$3.37$10.7KSEC ↗
Jul 24, 2026
ANIXcluster
3,000$3.73$11.2KSEC ↗
Jul 20, 2026
ANIXcluster
5,000$3.46$17.3KSEC ↗
Jul 10, 2026
ANIXcluster
5,000$3.04$15.2KSEC ↗

Follow new qualifying clusters involving KUMAR AMIT or other insiders

Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.

About this data

Figures are parsed from KUMAR AMIT's Form 4 filings on SEC EDGAR (CIK 1191905) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.